Literature DB >> 23053743

Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations.

Alessandra Silvestri1, Valerie Calvert, Claudio Belluco, Michael Lipsky, Ruggero De Maria, Jianghong Deng, Alfonso Colombatti, Francesco De Marchi, Donato Nitti, Enzo Mammano, Lance Liotta, Emanuel Petricoin, Mariaelena Pierobon.   

Abstract

The mechanism by which tissue microecology influences invasion and metastasis is largely unknown. Recent studies have indicated differences in the molecular architecture of the metastatic lesion compared to the primary tumor, however, systemic analysis of the alterations within the activated protein signaling network has not been described. Using laser capture microdissection, protein microarray technology, and a unique specimen collection of 34 matched primary colorectal cancers (CRC) and synchronous hepatic metastasis, the quantitative measurement of the total and activated/phosphorylated levels of 86 key signaling proteins was performed. Activation of the EGFR-PDGFR-cKIT network, in addition to PI3K/AKT pathway, was found uniquely activated in the hepatic metastatic lesions compared to the matched primary tumors. If validated in larger study sets, these findings may have potential clinical relevance since many of these activated signaling proteins are current targets for molecularly targeted therapeutics. Thus, these findings could lead to liver metastasis specific molecular therapies for CRC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053743      PMCID: PMC5564304          DOI: 10.1007/s10585-012-9538-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  Laser-capture microdissection.

Authors:  Virginia Espina; Julia D Wulfkuhle; Valerie S Calvert; Amy VanMeter; Weidong Zhou; George Coukos; David H Geho; Emanuel F Petricoin; Lance A Liotta
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarrays.

Authors:  Mary Winters; Bhavana Dabir; Minshu Yu; Elise C Kohn
Journal:  Proteomics       Date:  2007-11       Impact factor: 3.984

3.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 4.  Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

Authors:  Emanuel F Petricoin; Verena E Bichsel; Valerie S Calvert; Virginia Espina; Mary Winters; Lynn Young; Claudio Belluco; Bruce J Trock; Marc Lippman; David A Fishman; Dennis C Sgroi; Peter J Munson; Laura J Esserman; Lance A Liotta
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

5.  Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation.

Authors:  Kajsa Ericson; Christine Gan; Ian Cheong; Carlo Rago; Yardena Samuels; Victor E Velculescu; Kenneth W Kinzler; David L Huso; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-20       Impact factor: 11.205

6.  Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma.

Authors:  Eduardo Méndez; Wenhong Fan; Peter Choi; S Nicholas Agoff; Mark Whipple; D Gregory Farwell; Neal D Futran; Ernest A Weymuller; Lue-Ping Zhao; Chu Chen
Journal:  Head Neck       Date:  2007-09       Impact factor: 3.147

Review 7.  Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.

Authors:  Runa Speer; Julia Wulfkuhle; Virginia Espina; Robyn Aurajo; Kirsten H Edmiston; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2007 May-Jun       Impact factor: 4.069

Review 8.  Metastatic colorectal cancer-past, progress and future.

Authors:  Kathryn Field; Lara Lipton
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 9.  Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis.

Authors:  Keltouma Driouch; Thomas Landemaine; Soraya Sin; ShaoXiao Wang; Rosette Lidereau
Journal:  Clin Exp Metastasis       Date:  2007-11-01       Impact factor: 5.150

10.  KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.

Authors:  Antoine Italiano; Isabelle Hostein; Isabelle Soubeyran; Thibault Fabas; Daniel Benchimol; Serge Evrard; Jean Gugenheim; Yves Becouarn; René Brunet; Marianne Fonck; Eric François; Marie-Christine Saint-Paul; Florence Pedeutour
Journal:  Ann Surg Oncol       Date:  2010-01-05       Impact factor: 5.344

View more
  8 in total

1.  A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.

Authors:  Elisa Pin; Steven Stratton; Claudio Belluco; Lance Liotta; Ray Nagle; K Alex Hodge; Jianghong Deng; Ting Dong; Elisa Baldelli; Emanuel Petricoin; Mariaelena Pierobon
Journal:  Mol Oncol       Date:  2016-10-14       Impact factor: 6.603

2.  Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.

Authors:  Mariaelena Pierobon; Corinne Ramos; Shukmei Wong; K Alex Hodge; Jessica Aldrich; Sara Byron; Stephen P Anthony; Nicholas J Robert; Donald W Northfelt; Mohammad Jahanzeb; Linda Vocila; Julia Wulfkuhle; Guido Gambara; Rosa I Gallagher; Bryant Dunetz; Nicholas Hoke; Ting Dong; David W Craig; Massimo Cristofanilli; Brian Leyland-Jones; Lance A Liotta; Joyce A O'Shaughnessy; John D Carpten; Emanuel F Petricoin
Journal:  Clin Cancer Res       Date:  2017-04-26       Impact factor: 12.531

3.  Dynamic protein pathway activation mapping of adipose-derived stem cell differentiation implicates novel regulators of adipocyte differentiation.

Authors:  Bridget Wilson; Lance A Liotta; Emanuel Petricoiniii
Journal:  Mol Cell Proteomics       Date:  2013-06-07       Impact factor: 5.911

Review 4.  Reverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Use.

Authors:  Stefanie Boellner; Karl-Friedrich Becker
Journal:  Microarrays (Basel)       Date:  2015-03-24

5.  Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.

Authors:  Erika Maria Parasido; Alessandra Silvestri; Vincenzo Canzonieri; Claudio Belluco; Maria Grazia Diodoro; Massimo Milione; Flavia Melotti; Ruggero De Maria; Lance Liotta; Emanuel F Petricoin; Mariaelena Pierobon
Journal:  Oncotarget       Date:  2017-07-25

Review 6.  From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.

Authors:  Guido Gambara; Manuela Gaebler; Ulrich Keilholz; Christian R A Regenbrecht; Alessandra Silvestri
Journal:  Front Pharmacol       Date:  2018-02-14       Impact factor: 5.810

7.  Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway.

Authors:  Justin B Davis; Valerie Calvert; Steven Roberts; Sabrina Bracero; Emanuel Petricoin; Robin Couch
Journal:  Heliyon       Date:  2018-05-14

8.  Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light.

Authors:  Janine G Einspahr; Clara Curiel-Lewandrowski; Valerie S Calvert; Steven P Stratton; David S Alberts; James Warneke; Chengcheng Hu; Kathylynn Saboda; Elisabeth L Wagener; Sally Dickinson; Zigang Dong; Ann M Bode; Emanuel F PetricoinIII
Journal:  NPJ Precis Oncol       Date:  2017-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.